scholarly journals Management of Insomnia in Hemodialysis Patients: A Literature Review

2020 ◽  
Vol 13 (2) ◽  
pp. 93-99
Author(s):  
Nisrina Nur Aini ◽  
Arina Maliya
Keyword(s):  
Literature Review ◽  
Sleep Disorders ◽  
Hemodialysis Patients ◽  
Pharmacological Therapy ◽  
Dialysis Patients ◽  
Pharmacological Management ◽  
Results Management ◽  
Stage Renal Disease ◽  
End Stage

Introduction: Hemodialysis (HD) therapy is the most common therapy for patients with End Stage Renal Disease (ESRD). Insomnia prevalent among dialysis patients which affects their quality of life and death. Although hemodialysis therapy has been proven to prolong survival, the action of hemodialysis therapy has complications that cause symptoms, one of which is sleep disturbance. Complaints of sleep disorders that are often encountered in dialysis units are experienced by 50-80% of dialysis patients. Of the various sleep disorders, insomnia is one of the symptoms that is often experienced by ESRD patients. Methods: A literature review comparing several literatures through the search of accredited journal sites such as PubMed, Elsevier, ResearchGate, and Neliti with the keywords management insomnia in hemodialysis patients in the 2015-2020 period. Research Results: Management of insomnia is reviewed with the aim of providing guidance to encourage treatment. In the six journals reviewed, education on sleep hygiene, CBT-I, relaxation therapy, massage therapy, and drug administration (with caution) improving the quality of sleep for hemodialysis patients. Conclusions: Pharmacological and non-pharmacological management to overcome insomnia in hemodialysis patients can be given by considering the factors that influence it. Management is advised to use a nonpharmacological approach first. The administration of pharmacological therapy is recommended only for short-term use, used with caution in hemodialysis patients.

Sleep disorders in dialysis patients

2008 ◽  
Vol 31 (11) ◽  
pp. 919-927 ◽  
Author(s):  
G.C. Kosmadakis ◽  
J.F. Medcalf
Keyword(s):  
Sleep Disorders ◽  
Central Sleep Apnea ◽  
Poor Sleep ◽  
Dialysis Patients ◽  
Periodic Limb Movement Disorder ◽  
Sleep Related Breathing Disorders ◽  
Breathing Disorders ◽  
Stage Renal Disease ◽  
End Stage

Poor sleep and sleep-related breathing disorders are common in patients with end-stage renal disease (ESRD) but are often unrecognized and undertreated. Sleep disorders are known negative prognostic factors for morbidity and mortality. The most frequent sleep disorders seen in patients with ESRD are conditioned insomnia, excessive daytime sleepiness, obstructive or central sleep apnea (SA), as well as restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). Several uremic and nonuremic factors are thought to participate in the pathogenesis of sleep disorders in patients with ESRD. The therapy of sleeping disorders includes nonpharmacological and pharmacological measures that can improve the functionality and quality of life in patients with ESRD.

scholarly journals Duchenne Smile is Associated with Quality of Life and Survival in Hemodialysis Patients

2020 ◽  
Vol 44 (3) ◽  
pp. 313-325
Author(s):  
Mabel Aoun ◽  
Ghassan Sleilaty ◽  
Leony Antoun ◽  
Racha Dib ◽  
Dania Chelala
Keyword(s):  
Quality Of Life ◽  
Hemodialysis Patients ◽  
Physical Component Score ◽  
Dialysis Patients ◽  
Duchenne Smile ◽  
Health Related Qol ◽  
Health Related ◽  
Stage Renal Disease ◽  
End Stage

Objectives: Hemodialysis is the most used renal replacement modality for end-stage renal disease patients. Dialysis patients are usually assessed for quality of life (QoL) but smiling was never studied. Duchenne smile is a genuine expression of joy, associated with better survival in some groups of the general population. In this study, we aimed to evaluate whether the smile of dialysis patients can predict their QoL and mortality. Methods: All hemodialysis patients in Saint-George Hospital were included in this prospective study. Patients were interviewed using the Health-Related QoL questionnaire and followed for 10 days for smile screening. Those who smiled more than 34% of time were considered as smiling, then followed for death over 2 years. Results: Overall, 71 patients were studied. Duchenne smile was associated with death at 1 and 2 years (HR = 0.194 [95% CI 0.039-0.958], p = .044) but not with sex or diabetes. Smiling showed a statistically significant correlation with older age, fewer hospitalizations, vitality, physical component score, several QoL scores and general health. Conclusions: A simple observation of patients' Duchenne smile by nephrologists in hemodialysis units can give an idea about their QoL and 2-year survival.

Effect of Intradialytic Parenteral Nutrition on Quality of Life in Hemodialysis Patients

1993 ◽  
Vol 16 (8) ◽  
pp. 599-603 ◽  
Author(s):  
M.S. Siskind ◽  
Y-H. H. Lien
Keyword(s):  
Quality Of Life ◽  
Parenteral Nutrition ◽  
High Efficiency ◽  
Hemodialysis Patients ◽  
Dialysis Session ◽  
Eligibility Requirements ◽  
Stage Renal Disease ◽  
End Stage ◽  
Intradialytic Parenteral Nutrition

The purpose of this study was to determine the effect of intradialytic parenteral nutrition (IDPN) on the quality of life of malnourished patients with end-stage renal disease on high-efficiency and high-flux hemodialysis therapy. Patients, who met the Medicare eligibility requirements for IDPN, were asked to fill out and extensive questionnaire covering several measures of quality of life prior to initiating and again after completing four months of IDPN therapy. Although the IDPN improved serum albumin levels significantly, aside from improved sleep patterns, no significant improvements in quality of life could be demonstrated. The mortality rate of these enrolled patients was as high as 28% within 4 months. We concluded that the limited amount of nutrition delivered over the course of a short dialysis session may not be enough to appreciably change the lives of our malnourished patients.

scholarly journals Physical Activity and Quality of Sleep in Patients with End-Stage Renal Disease on Hemodialysis: A Preliminary Report

2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Vasiliki Theodorou ◽  
Eleni Karetsi ◽  
Zoe Daniil ◽  
Konstantinos I. Gourgoulianis ◽  
Vasileios T. Stavrou
Keyword(s):  
Physical Activity ◽  
Sleep Quality ◽  
Pittsburgh Sleep Quality Index ◽  
Social Activity ◽  
Hemodialysis Patients ◽  
Quality Of Sleep ◽  
Daily Lives ◽  
Stage Renal Disease ◽  
End Stage

Chronic kidney disease significantly impairs patients’ daily lives and worsens their quality of life. The aim of this study was to investigate the physical activity and quality of sleep, during three days (previous day of dialysis, on the day of dialysis and after day of dialysis), in patients with end-stage renal on hemodialysis. 12 hemodialysis patients were included in our study, answered the Pittsburgh Sleep Quality Index (PSQI) questionnaire, and for each patient were used a smart bracelet for three days (day-pre- and posthemodialysis and day at hemodialysis) to record daily physical activity (steps, distance) and estimate the quality of sleep. Results showed differences between three days average of steps and distance and PSQI parameters “…engaging in social activity?” (steps, p=0.006, distance, p=0.006) and “…enthusiasm to get things done?” (steps, p=0.029, distance, p=0.030). Our study suggests interrelationship between sleep quality and physical activity.

scholarly journals Health-Related Quality of Life in End-Stage Renal Disease Patients: How Often Should We Ask and What Do We Do with the Answer?

2016 ◽  
Vol 41 (1-3) ◽  
pp. 218-224 ◽  
Author(s):  
Shan Shan Chen ◽  
Saleem Al Mawed ◽  
Mark Unruh
Keyword(s):  
Quality Of Life ◽  
Patient Reported Outcomes ◽  
Dialysis Patients ◽  
Patient Reported ◽  
Related Quality ◽  
Health Related ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients

Background: End-stage renal disease (ESRD) patients have poor health-related quality of life (HRQOL) comparing to general population and comparable HRQOL to patients with other major chronic diseases. Poor HRQOL is associated with shorter survival. There is a limited threshold to which dialysis dose and parameters management can improve HRQOL in ESRD patients. Numerous studies have sought to find interventions to improve HRQOL. This article is to review the symptoms associated with poor HRQOL and how frequent the quality of life (QOL) should be evaluated to improve the outcome. Summary: It is required by the Center for Medicare and Medicaid Services to evaluate HRQOL of dialysis patients annually. KDIGO recommends the symptoms to be assessed regularly and the treatment is redirected toward a patient-centered care model. Studies have shown that measuring patient-reported outcomes frequently, from 4 times a day to every 3-6 months, without intervention did not improve the HRQOL significantly. Appropriate intervention of the symptoms may improve the quality of life (QOL). Studies in oncology have also showed a similar result. The commonly used tools to evaluate the HRQOL in dialysis patients take up to 30 min for completion. Therefore, frequent assessment of all the symptoms can provide more burden than benefit to the patients. In addition to the annual HRQOL measurements, more frequent evaluation of targeted symptoms can be helpful. For appropriate intervention of the symptoms, effective communication between providers, as well as a multidisciplinary approach, is essential to improve HRQOL and outcomes in dialysis patients. Key Messages: Measurement of patient-reported outcomes may provide an opportunity to improve outcomes in ESRD. The frequent measurement of symptoms and QOL may be burdensome. Consider targeted measurement of symptoms to complement HRQOL measurement. Improved communication and the use of a multidisciplinary team provide mechanisms to improve HRQOL in ESRD.

Formal literature review of quality-of-life instruments used in end-stage renal disease

2000 ◽  
Vol 36 (2) ◽  
pp. 327-336 ◽  
Author(s):  
Kathleen A. Cagney ◽  
Albert W. Wu ◽  
Nancy E. Fink ◽  
Mollie W. Jenckes ◽  
Klemens B. Meyer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Literature Review ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
Quality Of Life Instruments

scholarly journals Literature Review : Efektivitas Terapi Non Farmakologi Terhadap Penurunan Tekanan Darah Pada Pasien End Stage Renal Disease Yang Menjalani Hemodialisis

2021 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Nurul Pradita ◽  
Kiki Hardiansyah Safitri
Keyword(s):  
Blood Pressure ◽  
Literature Review ◽  
Renal Disease ◽  
Study Design ◽  
End Stage Renal Disease ◽  
Pharmacological Therapy ◽  
Online Database ◽  
Stage Renal Disease ◽  
End Stage ◽  
E Mail

Literature Review : Efektivitas Terapi Non Farmakologi Terhadap Penurunan Tekanan Darah Pada Pasien End Stage Renal Disease Yang Menjalani Hemodialisis Nurul Pradita1, Kiki Hardiansyah Safitri2 1 Mahasiswa Program Studi NERS, ITKES Wiyata Husada, Jl.Kadrie Oening No 77 Samarinda, Kalimantan Timur e-mail : [email protected] 2Dosen, ITKES Wiyata Husada, Jl.Kadrie Oening No 77 Samarinda, Kalimantan Timur e-mail : [email protected]   ABSTRAK   Latar Belakang: End Stage renal disease (ESRD) bisa disebabkan oleh tekanan darah yang tidak terkontrol  (hipertensi) atau  penyakit ginjal dapat menyebabkan hipertensi. Terapi non farmakologi dapat membantu pasien mengatasi tekanan darah dengan efek samping yang minimal. Tujuan: Mengidentifikasi studi literatur efektifitas terapi non farmakologi terhadap penurunan tekanan darah pada pasien end stage renal disease. Metode: Desain penelitian Literature  Review, online database adalah jurnal Science Direct, PubMed(NCBI), google scholar. Jurnal yang digunakan dalam kurun kurun waktu 2012-2020, pencarian menggunakan Populasi : pasien ESRD dengan hipertensi, intervensi :terapi non farmakologi, comparison: terapi komplomentar, outcome:penurunan tekanan darah, study design : literature review dan quasi experiment. Hasil: Didapatkan 6893 jurnal, diseleksi menggunakan kriteria inklusi dan ekslusi,melalui diagram prisma didapatkan menjadi 12 jurnal. Terapi non farmakologi yang digunakan adalah progressive muscel relaxation (4 jurnal); terapi massase (1 jurnal ); terapi music (4 jurnal); intradialitic exercise (4 jurnal) Kesimpulan: Terapi non farmakologi bermakna di dalam studi literature untuk menurunkan tekanan darah yang bekerja dengan prinsip relaksasi, berpengaruh dalam peningkatan hormon endorphin yang menyebabkan pembuluh darah berdilatasi sehingga tekanan darah mengalami penurunan. Kata Kunci : Terapi Non farmakologi, Hipertensi , End Stage Renal Disease   ABSTRACT   Background: End Stage Renal Disease (ESRD) can be caused by uncontrolled blood pressure (hypertension) or kidney disease can cause hypertension. Non-pharmacological therapy can help patients with blood pressure with minimal side effects. Objective: To conduct a literature study on the effectiveness of non-pharmacological therapies in reducing blood pressure of End Stage Renal Disease patients. Method: Literature Review research design, the data were obtained from online database such as Science Direct, PubMed (NCBI), and google scholar in the period of 2012-2020. The Population in this study was ESRD patients with hypertension and the intervention given were non-pharmacological therapies, comparison: commentary therapy, outcome: lowering blood pressure, study design: literature review and quasi experiment. Results: There were 6893 journals, selected using inclusion and exclusion criteria, through the PRISMA diagram they were narrowed down into 12 journals. The non-pharmacological therapies used were progressive muscle relaxation (4 journals); massage therapy (1 journal); music therapy (4 journals); and intradialytic exercise (4 journals). Conclusion: Non-pharmacological therapy is significant in literature studies to reduce blood pressure which works with the principle of relaxation. Further, it has an effect in increasing the endorphin hormone which causes blood vessels to dilate and lead to decreasing blood pressure.   Keywords: Non pharmacological, Hypertension, End Stage Renal Disease

scholarly journals Quality of Life for End-Stage Renal Disease (ESRD) PatientsUndergoing Peritoneal Dialysis (PD) Therapy: A Literature Review

2019 ◽  
Vol 1 (1) ◽  
Author(s):  
M. Hanif Prasetya 'Adhi ◽  
Yanny Trisyani ◽  
Etika Emaliyawati
Keyword(s):  
Quality Of Life ◽  
Peritoneal Dialysis ◽  
Case Report ◽  
Literature Review ◽  
End Stage Renal Disease ◽  
Meta Analyses ◽  
Stage Renal Disease ◽  
End Stage ◽  
Mesh Database

Introduction: ESRD adalah diagnosis akhir yang membutuhkan terapi pengganti ginjal seumur hidup seperti hemodialisa, peritoneal dialysis (PD) dan transplantasi ginjal. Populasi di dunia dan prevalensi penyakit ginjal stadium akhir terus meningkat, pasien semakin dihadapkan dengan keputusan untuk memulai terapi pengganti ginjal. Penelitian dan literature review yang menilai dampak perawatan terapi PD pada pasien ESRD masih terbatas. Tujuan dari literature review ini untuk menganalisis terapi CAPD pada pasien ESRD. Pencarian terbatas pada database elektronik seperti Pubmed, Proquest, dan Google Scholar, dengan kata kunci “ESRD”,”CAPD”,“Peritoneal Dialysis”,“Quality of Life” disusun berdasarkan MeSH Database dari NCBI. Methods: Strategi review artikel menggunakan PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analyses) dan dianalisa menggunakan konten analisis. Studi yang diterbitkan antara tahun 2009-2019, artikel penelitian dengan bahasa inggris, dipertimbangkan sebagai kriteria inklusi dalam tinjauan ini. Results: Didapatkan 25 artikel; 15 kuantitatif, 7 kualitatif, 2 case report dan 1 mixed methods. Discussion: Domain fisik; PD memberikan kelebihan pada peran-fisik, vitalitas, energik, dan bebas nyeri. Domain psikologis; PD menimbulkan depresi dan kecemasan yang lebih rendah daripada HD, bahkan 1 studi menyebutkan HD dapat menyebabkan depresi berat. Hubungan sosial; PD memberikan kemandirian pada gaya hidup, efikasi diri, kebebasan beraktivitas, fleksibilitas, dan mempertahankan kehidupan normal. Hubungan terkait lingkungan; pasien dengan PD lebih mungkin untuk melanjutkan pekerjaan mereka sehingga mereka secara finansial lebih baik dan lebih bebas untuk bepergian daripada HD, penghasilan terus dapat secara signifikan berkontribusi pada kesejahteraan pasien CAPD. Conclusion: PD terbukti memberikan kualitas hidup yang lebih baik. Dengan demikian, penting untuk mengembangkan terapi PD pada pasien ESRD yang membutuhkan dialisis jangka panjang, bahkan seumur hidup.

Sign in / Sign up

Export Citation Format

Share Document